tiprankstipranks

Private Equity Natixis Insider Profile

4 Followers
Private Equity Natixis, Ten Percent Owner at Kiora Pharmaceuticals, holds 674.21K shares in Kiora Pharmaceuticals (Ticker: KPRX). Most recently, Private Equity Natixis Bought $771,846 shares of Kiora Pharmaceuticals on Feb 23, 2015 for an estimated value of 410.09K.
tipranks
Private Equity Natixis

Private Equity Natixis
Kiora Pharmaceuticals (KPRX)
Ten Percent Owner

Not Ranked
Private Equity Natixis has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$327K
100.00%
A breakdown of Private Equity Natixis's holdings

Insider Roles

Kiora Pharmaceuticals
(KPRX)
Ten Percent Owner
Roles that Private Equity Natixis holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Private Equity Natixis

Private Equity Natixis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kiora Pharmaceuticals
Feb 23, 2015
Ten Percent Owner
Informative Buy
410.09K
$326.99K
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 23, 2015
Informative Buy
$410.09K
-
$1.06
List of latest transactions for each holding click on a transaction to see Private Equity Natixis's performance on stock

Private Equity Natixis insider profile FAQ

What is the percentage of profitable transactions made by Private Equity Natixis?
The percentage of profitable transactions made by Private Equity Natixis is ―.
    What is the average return per transaction made by Private Equity Natixis?
    The average return per transaction made by Private Equity Natixis is ―.
      What stocks does Private Equity Natixis hold?
      Private Equity Natixis holds: KPRX stocks.
        What was Private Equity Natixis’s latest transaction?
        Private Equity Natixis latest transaction was an Informative Buy of $410.09K.
          What was Private Equity Natixis's most profitable transaction?
          Private Equity Natixis’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Private Equity Natixis's role in Kiora Pharmaceuticals?
            Private Equity Natixis's role in Kiora Pharmaceuticals is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.